While still not from BOT so therefore take it with a grain of salt, this is from the E&P report - Page 41
In the U.S., seven major plans cover approximately 80% of lives, making these engagements crucial. While the progress of thesenegotiations remains somewhat opaque and reliant on optimistic company guidance, it is assumed that Sofdra will be reimbursed at alevel commensurate with a unit list price of approximately $750 per prescription, with a gross-to-net adjustment of around 30%.
- Forums
- ASX - By Stock
- BOT
- Ann: FDA Approves Sofdra
Ann: FDA Approves Sofdra, page-285
-
- There are more pages in this discussion • 217 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
33.0¢ |
Change
-0.010(2.94%) |
Mkt cap ! $606.3M |
Open | High | Low | Value | Volume |
34.0¢ | 34.0¢ | 33.0¢ | $303.2K | 901.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 895898 | 33.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.5¢ | 53624 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 777424 | 0.330 |
21 | 901765 | 0.325 |
18 | 831650 | 0.320 |
15 | 954882 | 0.315 |
15 | 1009867 | 0.310 |
Price($) | Vol. | No. |
---|---|---|
0.335 | 53624 | 3 |
0.340 | 689378 | 9 |
0.345 | 426200 | 8 |
0.350 | 332050 | 10 |
0.355 | 133069 | 6 |
Last trade - 11.00am 08/07/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |